These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26059226)

  • 1. HIV-1 Rev downregulates Tat expression and viral replication via modulation of NAD(P)H:quinine oxidoreductase 1 (NQO1).
    Lata S; Ali A; Sood V; Raja R; Banerjea AC
    Nat Commun; 2015 Jun; 6():7244. PubMed ID: 26059226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes.
    Willard-Gallo KE; Furtado M; Burny A; Wolinsky SM
    Eur J Immunol; 2001 Apr; 31(4):969-79. PubMed ID: 11298321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The post-transcriptional regulator Rev of HIV: implications for its interaction with the nucleolar protein B23.
    Miyazaki Y; Nosaka T; Hatanaka M
    Biochimie; 1996; 78(11-12):1081-6. PubMed ID: 9150888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust growth of human immunodeficiency virus type 1 (HIV-1).
    Kim H; Yin J
    Biophys J; 2005 Oct; 89(4):2210-21. PubMed ID: 16055539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev.
    Ragheb JA; Couture L; Mullen C; Ridgway A; Morgan RA
    Hum Gene Ther; 1999 Jan; 10(1):103-12. PubMed ID: 10022535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals.
    Truant R; Cullen BR
    Mol Cell Biol; 1999 Feb; 19(2):1210-7. PubMed ID: 9891055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines.
    Ranki A; Lagerstedt A; Ovod V; Aavik E; Krohn KJ
    Arch Virol; 1994; 139(3-4):365-78. PubMed ID: 7832642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular trafficking and interactions of the HIV-1 Tat protein.
    Stauber RH; Pavlakis GN
    Virology; 1998 Dec; 252(1):126-36. PubMed ID: 9875323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA binding by the tat and rev proteins of HIV-1.
    Karn J; Dingwall C; Finch JT; Heaphy S; Gait MJ
    Biochimie; 1991 Jan; 73(1):9-16. PubMed ID: 1903308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional and post-transcriptional regulation of HIV-1 gene expression: role of cellular factors for Tat and Rev.
    Nekhai S; Jeang KT
    Future Microbiol; 2006 Dec; 1(4):417-26. PubMed ID: 17661632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes.
    Bauer G; Valdez P; Kearns K; Bahner I; Wen SF; Zaia JA; Kohn DB
    Blood; 1997 Apr; 89(7):2259-67. PubMed ID: 9116267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
    Ulich C; Harrich D; Estes P; Gaynor RB
    J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
    Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
    Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference.
    Coburn GA; Cullen BR
    J Virol; 2002 Sep; 76(18):9225-31. PubMed ID: 12186906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 replication by cell-penetrating peptides binding Rev.
    Roisin A; Robin JP; Dereuddre-Bosquet N; Vitte AL; Dormont D; Clayette P; Jalinot P
    J Biol Chem; 2004 Mar; 279(10):9208-14. PubMed ID: 14668323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of HIV-1: positive and negative regulatory elements important for virus expression.
    Felber BK; Pavlakis GN
    AIDS; 1993; 7 Suppl 1():S51-62. PubMed ID: 8363803
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
    Schwartz S; Felber BK; Pavlakis GN
    J Virol; 1992 Jan; 66(1):150-9. PubMed ID: 1727477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of HIV-1 gene expression and transcription.
    Baba M
    Curr Top Med Chem; 2004; 4(9):871-82. PubMed ID: 15134546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.
    Luo Y; Madore SJ; Parslow TG; Cullen BR; Peterlin BM
    J Virol; 1993 Sep; 67(9):5617-22. PubMed ID: 8350414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.